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Background: Colorectal cancer is a leading cause of cancer-related death, and inﬂammatory bowel dis-
ease is a risk factor for this malignancy. We previously reported colon cancer chemoprevention potential
using American ginseng (AG) in a xenograft mice model. However, the nude mouse model is not a gut-
speciﬁc colon carcinogenesis animal model.
Methods: In this study, an experimental colitis and colitis-associated colorectal carcinogenesis mouse
model, chemically induced by azoxymethane/dextran sodium sulfate (DSS) was established and the
effects of oral AG were evaluated. The contents of representative ginseng saponins in the extract were
determined.
Results: AG signiﬁcantly reduced experimental colitis measured by the disease activity index scores. This
suppression of the experimental colitis was not only evident during DSS treatment, but also very obvious
after the cessation of DSS, suggesting that the ginseng signiﬁcantly promoted recovery from the colitis.
Consistent with the anti-inﬂammation data, we showed that ginseng very signiﬁcantly attenuated
azoxymethane/DSS-induced colon carcinogenesis by reducing the colon tumor number and tumor load.
The ginseng also effectively suppressed DSS-induced proinﬂammatory cytokines activation using an
enzyme-linked immunosorbent assay array, in which 12 proinﬂammatory cytokine levels were assessed,
and this effect was supported subsequently by real-time polymerase chain reaction data.
Conclusion: AG, as a candidate of botanical-based colon cancer chemoprevention, should be further
investigated for its potential clinical utility.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Colorectal cancer is one of the most common malignancies
worldwide [1,2], and the 5-year survival rate is < 10% in the
advanced stages [3]. Numerous effective drugs, including thoseedicine Research, The Pritzker Sc
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botanical sources [4,5]. Thus, there still is a signiﬁcant unexploited
resource in herbal medicines.
In our previous studies, we assessed the colon cancer chemo-
prevention potential of American ginseng, a very commonly usedhool of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4028,
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Fig. 1. Experimental protocol. Experimental A/J mice were divided into three groups,
i.e., control (or negative control) group, model group, and American ginseng (AG)
group. Animals in the model and AG groups initially received a single intraperitoneal
injection of azoxymethane (AOM; 7.5 mg/kg). One week after the AOM administration
(set as Day 1), mice in the model and AG groups received 2.5% dextran sodium sulfate
(DSS) in drinking water for 8 consecutive days. Mice in the AG group also received oral
AG extract 30 mg/kg/day for 90 consecutive days (Day 1e14 is the acute phase and
then up to 90 days is the chronic phase).
C. Yu et al / Ginseng and colon cancer 15herbal medicine in the USA. [6,7]. In an in vivo investigation, the
tumor xenograft nude mice model was used and signiﬁcant anti-
tumor effects of ginseng compounds were observed [8]. However,
the xenograft mice model was not a commonly appreciated model
for colon cancer studies. In addition, the ginseng compound was
administrated via intraperitoneal injection, an experimental
approach, compared to the real world in which the route of
administration of herbal medicines in humans is nearly always oral.
Inﬂammatory bowel disease is a group of chronic dysregulated
inﬂammatory conditions in the large and small intestine of
humans, and it is well known that chronic inﬂammation in the
colon can lead to cancer [9e11]. An experimental colitis and colitis-
associated colorectal carcinogenesis mouse model, chemically
induced by azoxymethane (AOM)/dextran sodium sulfate (DSS),
has been used often for colorectal cancer research [12,13]. AOM is a
genotoxic colonic carcinogen frequently used to induce colon tu-
mors [14,15].
We previously evaluated the effects of American ginseng (AG) in
colorectal cancer chemoprevention in the AOM/DSS mouse model
using a high-fat diet (20% fat) to mimic Western food [16]. In the
present study, this established animal colon carcinogenesis model
was used inmice fedwith regularmouse chow (5% fat) reﬂecting an
oriental diet, with or without AG supplement. To ensure the quality
of the study botanical, high-performance liquid chromatography
(HPLC) analysis was performed on the herb, and the contents of a
number of important ginseng saponins were quantiﬁed. To extend
previous tumor-related protein regulator observations, in this
study, selected enzyme-linked immunosorbent assay (ELISA) for
inﬂammatory cytokines and quantitative real-time polymerase
chain reaction (qRT-PCR) were performed to elucidate the IBD
related mechanisms of action.
2. Materials and methods
2.1. Chemicals and reagents
Standards of ginsenosides Rb1, Rb2, Rb3, Rc, Rd, Re, Rg1, Rg2,
20(R)-Rg2, Rg3, and Rh1 were obtained from Indoﬁne Chemical
Company (Somerville, NJ, USA) and Delta Information Center for
Natural Organic Compounds (Xuancheng, AH, China). All standards
were of biochemical-reagent grade and at least 95% pure. AOMwas
obtained from the NCI Chemical Carcinogen Reference Standard
Repository, Midwest Research (Kansas City, MO, USA). DSS (mo-
lecular weight of 36e50 kDa) was obtained from MP Biomedicals
(Solon, OH, USA). HPLC grade ethanol, n-butanol, acetonitrile, and
dimethylsulfoxide were obtained from Fisher Scientiﬁc (Pittsburgh,
PA, USA). Milli Q water was supplied by a water puriﬁcation system
(US Filter, Palm Desert, CA, USA). Hemoccult Sensa test strips were
obtained from Beckman Coulter (Brea, CA, USA). Multi-Analyte
ELISArray Kits for inﬂammatory cytokine analysis were obtained
from Qiagen (Germantown, MD, USA).
2.2. Botanical materials and extract preparation
AG roots (4-year-old, Panax quinquefolius L.) were obtained from
Roland Ginseng, LLC (Marathon, WI, USA). The voucher samples
were authenticated by Dr Chong-Zhi Wang and deposited at the
Tang Center for Herbal Medicine Research at the University of
Chicago. AG extract was prepared with a slight modiﬁcation from
previous works [17e19]. The air-dried roots of AG were pulverized
into powder and sieved through an 80 mesh screen. One kilogram
of the powder placed into 12 L ﬂask was extracted three times by
heat-reﬂux with 8 L of 75% (v/v) ethanol at 95C for 4 h each time.
The extracting solution was ﬁltered when hot. The gathered and
combined ﬁltrate was evaporated under vacuum with a BüchiRotary Evaporator. The obtained extract was dissolved in 700 mL of
water. The solution was extracted 3 times with 500 mL of water-
saturated n-butanol. The mixed n-butanol phase was evaporated
under vacuum and then lyophilized.
2.3. HPLC analysis of herbal extract
Prior to pharmacological evaluation, the AG extract was
analyzed using HPLC [20,21]. The HPLC system was a Waters Alli-
ance 2960 instrument (Milford, MA, USA) with a quaternary pump,
an automatic injector, a photodiode array detector (Model 996),
and Waters Millennium 32 software for peak identiﬁcation and
integration. The separation was carried out on a Prodigy ODS(2)
column (250 mm  3.2 mm inner diameter) with a guard column
(3.0 mm  4.0 mm inner diameter) (Phenomenex, Torrance, CA,
USA). For HPLC analysis, a 20-mL sample was injected into the col-
umn and eluted at room temperature with a constant ﬂow rate of
1.0mL/min. For themobile phase, acetonitrile (solvent A) andwater
(solvent B) were used. Gradient elution started with 17.5% solvent A
and 82.5% solvent B. Elution solvents were then changed to 21% A
for 20 min, then to 26% A for 3 min and held for 19 min, at 36% A for
13 min, at 50% A for 9 min, at 95% A for 2 min, and held for 3 min.
Lastly, eluting solvents were changed to 17.5% A for 3 min and held
for 8 min. The detection wavelength was set at 202 nm. All sample
solutions were ﬁltered through a membrane ﬁlter (0.2 mm pore
size). The content of the constituents were calculated using the
standard curves of 13 ginsenosides. The measurement for the
content analysis of the AG was performed in triplicate.
2.4. Animals and treatment protocols
The experimental protocols were approved by the Institutional
Animal Care and Use Committee of the University of Chicago, Chi-
cago, IL, USA. All experiments were carried out in male A/J mice,
aged approximately 6 weeks, weighing 18e22 g, obtained from
Jackson Laboratories (Bar Harbor, ME, USA). Mice were maintained
under controlled room temperature, humidity, and light (12/12 h
light/dark cycle) and allowed ad libitum access to standard mouse
chow and tap water. The mice were allowed to acclimate to these
conditions for at least 7 days prior to inclusion in the experiments.
As shown in Fig. 1, animals were separated into three groups
(n ¼ 12 per group): control (or negative control), model, and AG
groups. All animals initially received a single intraperitoneal in-
jection of AOM (7.5 mg/kg). One week after the AOM injection (set
Table 1
Primers used for quantitative real-time polymerase chain reaction analysis of in-
ﬂammatory cytokines
Gene Primer Sequence
IL-1a Forward 50-CGAAGACTACAGTTCTGCCATT-30
Reverse 50-GACGTTTCAGAGGTTCTCAGAG-30
IL-1b Forward 50-GCAACTGTTCCTGAACTCAACT-30
Reverse 50-ATCTTTTGGGGTCCGTCAACT-30
IL-6 Forward 50-TAGTCCTTCCTACCCCAATTTCC-30
Reverse 50-TTGGTCCTTAGCCACTCCTTC-30
IFN-g Forward 50-ATGAACGCTACACACTGCATC-30
Reverse 50-CCATCCTTTTGCCAGTTCCTC-30
G-CSF Forward 50-ATGGCTCAACTTTCTGCCCAG-30
Reverse 50-CTGACAGTGACCAGGGGAAC-30
GM-CSF Forward 50-GGCCTTGGAAGCATGTAGAGG-30
Reverse 50-GGAGAACTCGTTAGAGACGACTT-30
b-actin Forward 50-GGCTGTATTCCCCTCCATCG-30
Reverse 50-CCAGTTGGTAACAATGCCATGT30
G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyteemacrophage
colony-stimulating factor; IFN, interferon; IL, interleukin, TNF, tumor necrosis factor
J Ginseng Res 2015;39:14e2116as Day 1), the animals began to receive 2.5% DSS in drinking water
for 8 consecutive days. The animals in AG group also received AG
extract 0.15 mg/mL in drinking water for up to 90 consecutive days.
We calculated that the daily dose of American ginseng was
approximately 30 mg/kg.C
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Fig. 2. Major ginsenosides in American ginseng (AG) extract. (A) Chemical structures of
ginsenosides in the AG extract. Glc, b-D-glucopyranosyl; Xyl, b-D-xylopyranosyl; Rha, a-L-rFor the acute phase observation, six animals per group were
sacriﬁced on Day 14. The remaining animals were kept in the
chronic phase and were sacriﬁced on Day 90. The gut tissue
samples of all animals were collected for further observations.2.5. Disease activity index
AOM/DSS induced colitis was scored as the disease activity in-
dex (DAI) as described previously [22]. In brief, the DAI was the
combined scores of weight loss (0, none; 1, 0e5%; 2, 5e10%; 3, 10e
20%; and 4,>20%), stool consistency change (0, none; 2, loose stool;
and 4, diarrhea), and bleeding (0, none; 1, trace; 2, mild hemoccult;
3, obvious hemoccult; and 4, gross bleeding), and then divided by
three. The animals were scored for the DAI at the same time of each
day, blind to the treatment. The minimal score was 0 and the
maximal score was 4.2.6. Histological assessment
Parafﬁn-embedded gut tissue samples were serially sectioned,
and some sections were stained with hematoxylin and eosin (H&E).
The stained sections were subsequently examined for histopatho-
logical changes by a gastrointestinal pathologist.Rb1 Rc Rb2 Rb3 Rd Rg3
Protopanaxadiol type
inutes
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11 ginsenosides. (B) Typical chromatograph of AG extract. (C) Contents of the major
hamnopyranosyl; Ara(f), a-L-arabinofuranosyl; Ara(p), a-L-arabinopyranosyl.
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Proteins of themouse colonic tissue that was collected on Day 14
were extracted with radio-immunoprecipitation assay lysis buffer
(Thermo Scientiﬁc, Hanover Park, IL, USA) adding 10 mL/mL pro-
teinase inhibitor cocktail and phosphatase inhibitor cocktail (Sigma,
St. Louis, MO, USA). ELISA was performed with Multi-Analyte ELI-
SArray Kit containing 12 mouse inﬂammatory cytokines [inter-
leukin (IL)1a, IL1b, IL2, IL4, IL6, IL10, IL12, IL17A, interferon (IFN)-g,
tumor necrosis factor-a (TNF-a), granulocyte colony-stimulating
factor (G-CSF), and granulocyteemacrophage colony-stimulating
factor (GM-CSF)] according to the manufacturer’s instructions.2.8. RNA extraction and quantitative RT-PCR
Total RNAwas isolated from the mouse colonic tissues using the
miRNeasy kit (QIAGEN, Valencia, CA, USA) based on the manufac-
turer’s instructions and was used as a template to synthesize cDNA
for qRT-PCR. First strand cDNA was synthesized using Thermo
Scientiﬁc Maxima First Strand cDNA Synthesis Kit. qRT-PCR was
performed on a 7900HT real-time PCR system (Applied Biosystems,
Foster City, CA, USA). qRT-PCR with SYBR Green dye (QIAGEN) was
used to determine the gene expression. Primers for qRT-PCR are
listed in Table 1. b-actin was used as an endogenous control. Each
sample was run in triplicate.D
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Fig. 3. Effects of American ginseng (AG) on azoxymethane/dextran sodium sulfate-induced
stained histological sections of control (or negative control), model, and AG groups. (B) AG
negative control) group are all zeros from Day 1 to Day 14, shown as a thick horizontal lin2.9. Statistical analysis
Data are presented as mean  standard deviation. Data were
analyzed using analysis of variance (ANOVA) for repeatedmeasures
and Student t test. The level of statistical signiﬁcance was set at
p < 0.05.
3. Results
3.1. HPLC analysis of AG saponins
The chemical structures of 11 major ginsenosides, in the pro-
topanaxadiol or protopanaxatriol groups, are shown in Fig. 2A. The
chromatograph of AG extract is shown in Fig. 2B. As shown in
Fig. 2C, the contents of protopanaxatriol type ginsenosides Rg1, Re,
Rh1, Rg2, and 20R-Rg2 in AG extract were 0.43%, 11.33%, 0.10%,
0.15%, and 0.13%, respectively, whereas the contents of proto-
panaxadiol type ginsenosides Rb1, Rc, Rb2, Rb3, Rd, and Rg3 were
38.89%, 2.24%, 0.50%, 0.62%, 2.68%, and 0.28%, respectively. The total
ginsenoside content was 57.4%.
3.2. AG reduced experimental colitis
Starting from Day 4 after DSS treatment, animals in the model
group showed apparent diarrhea and rectal bleeding. As DSSTime (day)
6 8 10 12 14
del AG
change in acute colitis (n ¼ 6 per group). (A) Representative hematoxylin and eosin
ameliorates the colitis, expressed as disease activity index. Data from the control (or
e.
J Ginseng Res 2015;39:14e2118administration continued, the presence and development of
inﬂammation manifested clearly. During the acute phase (Day 14),
H&E staining colon tissue from model animals showed: increas-
ingly severe inﬂammatory lesions extensively throughout the co-
lon; signiﬁcant and complete loss of crypts; surface erosion with
exuberant inﬂammatory exudates; patchy re-epithelization; lam-
ina propria ﬁbrosis with acute and chronic inﬂammatory inﬁltrate;
submucosal edema; andmixed inﬂammatory cell inﬁltration. In the
AG group, mucosa had tightly packed glands with a normal amount
of goblet cells (Fig. 3A). The disease severity, scored by the DAI,
reached its highest level on Day 8. Fig. 3B shows signiﬁcant effects
of AG on the reduction of the DAI score (p < 0.05). This suppression
of the experimental colitis by the herb was not only evident during
DSS treatment, but also very obvious after the cessation of DSS
administration (i.e., Day 8), suggesting that AG signiﬁcantly pro-
moted recovery from the colitis.3.3. AG attenuated on AOM/DSS-induced colon carcinogenesis
Fig. 4A is a representative macroscopic morphology for the
control group, model group, and AG group. Obvious tumorigenesis
was observed in the model group. However, in the AG treatment
group, the tumor number and size were signiﬁcantly less and
relative small. Fig. 4B shows representative H&E staining histo-
logical sections of the three groups. In the colon tissue from the
model animals, multifocal adenomatous lesion was observed, and
there was no invasion into submucosa; there was mildN
um
be
r o
f t
um
or
s
Model AG
10
15
20
25 p < 0.01
A
B
C
Fig. 4. Effects of American ginseng extract (AG) on azoxymethane/dextran sodium sulfa
morphology of colon tumors in the control (or negative control), model, and AG groups. A
sentative hematoxylin and eosin stained histological sections of control, model, and AG gr
compared to the model group (p < 0.01 and p < 0.001, respectively).inﬂammation with cryptitis, mild degree loss of goblet cells,
ﬁbrosis, and apoptotic changes. For the AG treatment group, mu-
cosa shows tightly packed glands with a normal amount of goblet
cells while crypt architecture remained normal. Compared to the
model, the histological sections of the AG treatment group aremore
similar to those of the control group.
Fig. 4C shows colon carcinogenesis data. Our results showed
that compared to the model group, AG treatment very signiﬁcantly
reduced the total number of colon tumors and load of tumors
(p < 0.01 and p < 0.001, respectively). Tumor distribution data
reﬂected this reduction, in which the number of large tumors (1e
2 mm and > 2 mm) decreased while the number of small tumors
(< 1 mm) increased.3.4. AG suppressed DSS-induced proinﬂammatory cytokines
activation
Previous studies have shown that blockade of inﬂammatory
cytokines signiﬁcantly decrease the severity of colitis. To explore
mechanisms of inhibition of AOM/DSS induced colitis and tumor-
igenesis by AG treatment, using an ELISA array, we determined
proinﬂammatory cytokine levels in the colon tissues collected on
Day 14. Colonic levels of the proinﬂammatory cytokines IL-1a, IL-
1b, IL-2, IL-4, IL-6, IL-10, IL-12, IL-17A, IFN-g, tumor necrosis factor-
a, G-CSF, and GM-CSF were markedly elevated in the DSS model
group. Treatment with AG signiﬁcantly inhibited the levels of those
12 cytokines by 44%, 35%, 42%, 39%, 46%, 34%, 37%, 44%, 51%, 40%,Lo
ad
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te-induced colon carcinogenesis (n ¼ 6 per group). (A) Representative macroscopic
rrows indicate the azoxymethane/dextran sodium sulfate-induced tumors. (B) Repre-
oups. (C) Number of colon tumor and load reduced very signiﬁcantly in the AG group
C. Yu et al / Ginseng and colon cancer 1946%, and 37%, respectively (p < 0.05; Fig. 5). This result suggested
that within the acute phase (Day 14), AG signiﬁcantly reduced the
levels of proinﬂammatory cytokines in colon tissue, which was
induced by DSS treatment.
3.5. AG downregulated inﬂammatory cytokine gene expression
To validate inﬂammatory cytokine data observed in the ELISA
analysis, we examined the effect of AG on the expression of in-
ﬂammatory cytokine genes in both the acute (Day 14) and chronic
(Day 90) phases. We used RT-PCR to test the effects of AG on the
target genes in colon tissues, which were collected on Day 14 and
Day 90. As shown in Fig. 6A, in the acute phase (Day 14), the
expression of six inﬂammatory cytokines (IL-1a, IL-1b, IL-6, IFN-g,
G-CSF, and GM-CSF) in the model group is much higher than in the
control group (all p < 0.001). Compared to the model, ginseng
treatment signiﬁcantly downregulated the expression of the tested
inﬂammatory cytokines (all p < 0.01). In the chronic phase (Day
90), similar effects were also observed, and AG treatment more
signiﬁcantly inhibited inﬂammatory cytokine expression (all
p < 0.001 vs. model; Fig. 6B). This result indicate that the oral
administration of AG transcriptionally repressed inﬂammatory cy-
tokines in the gut tissue.
4. Discussion
Colorectal cancer is the second leading cause of cancer-related
death in the West [2,23]. This cancer also remains a foremost cause
of morbidity and mortality, a signiﬁcant contributor to the burden
of disease of global public health. Inﬂammatory bowel disease,
including ulcerative colitis and Crohn’s disease, is a risk factor for
colon cancer initiation and development [10,11]. Nonsteroidal anti-
inﬂammatory drugs can reduce colon cancer tumorigenesis. For
example, celecoxib has potent preventive and therapeutic effects
on the cancer [24]. Concerns about the risks of long-term use of
such drugs, however, make this form of chemoprevention unsuit-
able as a general recommendation [25,26]. Epidemiological,
experimental, and clinical studies provide evidence that inﬂam-
matory phytochemicals possess unique modes of action against
cancer development and growth [27e29]. In the present study, the
effects of AG were investigated, as one of the efforts to search for
the botanical sources against this signiﬁcant medical problem.
Experimentally, AOM (a mutagenic agent) and/or DSS (a
proinﬂammatory reagent) have often been used in colorectal can-
cer chemoprevention animal studies [15,30e32]. In this study weFig. 5. Acute inﬂammatory responses in azoxymethane/dextran sodium sulfate model and A
from six mice, which was collected on Day 14. Cytokine expressions were analyzed using t
**p < 0.01, compared to the model group. G-CSF, granulocyte colony-stimulating factor; GM-C
TNF, tumor necrosis factor.used the AOM/DSS mouse model to mimic the inﬂamed colon and
carcinogenesis conditions in humans [15,33].
There were two observation phases in this study. The acute
phase (Day 1e14) reﬂected the manifestation of inﬂammatory co-
litis, measured by DAI (Fig. 3). The chronic phase (up to 90 days)
revealed the colon carcinogenesis (Fig. 4), measured by colon tumor
number and tumor load. Compared with the model group, we
observed that AG treatment signiﬁcantly attenuated the experi-
mental colitis. Our data also suggest that the AG not only could be
used to treat DSS-induced colitis during the induction by the
chemical, but also to promote the recovery from the colitis after the
cessation of DSS administration. In the chronic phase, our data
show that ginseng treatment very signiﬁcantly reduced colon tu-
mor number and load. The H&E staining histological observations
support these pharmacological observations.
We used HPLC analysis to determine the major ginsenosides in
the AG used in this study. Previously, we evaluated the effects of
another herb in the ginseng family, notoginseng, on experimental
colitis for up to 14 days. We reported that notoginseng attenuated
the acute colitis [34] comparable to what was observed using AG in
this study. Although the ginseng saponin proﬁles are different be-
tween AG and notoginseng, the two botanicals also share a number
of common ginsenosides. It would be interesting to identify which
is/are the key ginsenoside(s) responsible for the observed effects
reported in these two studies.
AG and Asian ginseng are two major ginseng species. These
two ginsengs, especially Asian ginseng, are the most studied
natural products in the world [35,36]. It is generally accepted
that the main bioactive constituents of both ginsengs are gin-
senosides [37,38]. Over 80 ginsenosides have been identiﬁed, and
nearly all these ginsenosides can be found in the two species.
However, the ginsenoside proﬁle between the two ginseng spe-
cies is different, and this difference may contribute to their
different pharmacological effects [18,35]. Of note, AG has
approximately two times higher total ginsenoside content than
Asian ginseng, largely due to its obvious high levels of Rb1, Re,
and Rd [35].
Using the extract of AG, Cui et al [39] showed that the extract
suppressed colon cancer associated with colitis in the AOM/DSS
model. In particular, these authors investigated the molecular
mechanisms of ginseng’s anticancer effects using antibody array
observations on colon cells isolated at a precancerous stage. Our
study also used oral ginseng administration, and it is likely that
enteric microbiome plays a role in ginseng metabolism and
bioavailability.merican ginseng (AG) treatment groups. Protein lysis was prepared using colonic tissue
he mouse cytokine Multi-Analyte ELISArray. *p < 0.05, compared to the model group.
SF, granulocyteemacrophage colony-stimulating factor; IFN, interferon; IL, interleukin,
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J Ginseng Res 2015;39:14e2120After AG is ingested orally, the bioavailability of its saponins is
low. This is due to incomplete absorption of the parent compounds
and their conversion into metabolites by the enteric microbiome,
mainly via step-wise cleavage of sugar moieties [35,40]. The
ginseng metabolites may possess more signiﬁcant pharmacological
beneﬁts than their parent compounds such as Rb1 [41], including
the effects observed in this study. Because the diarrhea induced by
DSS is likely to affect the activity and/or proﬁle of enteric micro-
biome, AOM/DSS-induced, colitis-associated colorectal carcino-
genesis may not be an ideal in vivo model to study the botanical
chemoprevention of colorectal cancer in relation to the enteric
microbiome. Future study should be extended to other colon cancer
animal models, especially the APC mutant Min (multiple intestinal
neoplasia) mice with detailed mechanisms of action [42,43].
Traditional medicine has been practiced for thousands of years
based on clinical experience. Modern research suggested that
herbal medicines could be used as adjuvants for cancer symptom
management and cancer therapeutics [44,45]. To explore the po-
tential role of AG in colorectal cancer chemoprevention, it is
necessary to integrate existing traditional knowledge of diseases
with modern biomedical technologies [46]. Data reported in this
study suggested that AG, as a candidate of botanical-based colon
cancer chemoprevention, should be further investigated for its
potential clinical utility.
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